{
    "bipacksedel": {},
    "produktresume": {},
    "fass_text": {},
    "bilder_och_delbarhet": {},
    "miljöinformation": {
        "env-effect": "Teikoplanin Miljörisk: Användning av teikoplanin har bedömts medföra försumbar risk för miljöpåverkan. Nedbrytning: Teikoplanin är potentiellt persistent. Bioackumulering: Teikoplanin har låg potential att bioackumuleras. Läs mer Detaljerad miljöinformation Environmental Risk Classification Predicted Environmental Concentration (PEC) PEC is calculated according to the following formula: PEC (µg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R) PEC = 9.39 * 10-5 µg/L Where: A = 0.68544 kg (total sold amount API in Sweden year 2020, data from IQVIA) R = 0% removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) P = number of inhabitants in Sweden = 10*106 V (L/day) = volume of wastewater per capita and day = 200 (Ref I) D = factor of dilution of waste water by surface water flow = 10 (Ref I) Predicted No Effect Concentration (PNEC) Ecotoxicological studies Algae (Anabaena flos-aquae): EC50 72 h (growth rate): 236 µg/L EC10 72 h (growth rate): 12.9 µg/L Protocol: OECD 201 (Ref II) Crustacean (Daphnia magna): EC50 48 h (immobilization): > 100 000 µg/L Protocol: OECD 202 (Ref III) Fish (Danio Rerio): LC50 96 h (lethality): > 100 000 µg/L Protocol: OECD 236 (Ref IV) Other ecotoxicity data: Lowest EC50/1000: Algae (Anabaena flos-aquae): EC50 72 h (growth rate): 236 µg/L PNEC : 236 µg/L/1000 = 0.236 µg/L Environmental Risk Classification (PEC/PNEC ratio) PEC/PNEC: 0.00040 1 < PEC/PNEC ≤ 0.1: Use of teicoplanin has been considered to result in insignificant environmental risk. Degradation Test showed 0% degradation in 28 days. Therefore, teicoplanin is considered to be potentially persistent. (Ref V) Bioaccumulation Partitioning coefficient: Teicoplanin has low potential for bioaccumulation, as indicated by a calculated log Kow of 0.8 (method/model: XLogP3-AA) (Ref VI) Excretion (metabolism) In 16 days, more than 80% of administered teicoplanin are excreted in urine as parent compound (Ref VII). Two metabolites (metabolites 1 and 2; 2 to 3% of total teicoplanin) have been isolated and their structures were found to be new teicoplanin-like molecules, bearing 8-hydroxydecanoic and 9-hydroxydecanoic acyl moieties, respectively. (Ref VIII) References ECHA, European Chemicals Agency, 2008 Guidance on information requirements and chemical safety assessment. https://echa.europa.eu/sv/guidance-documents/guidance-on-information-requirements-and-chemical-safety-assessment Sanofi Internal report: Teicoplanin: Toxicity to Anabaena flos-aquae in an Algal Growth Inhibition Test, Study No 127621218, April 2018 Sanofi internal report: : Teicoplanin : Acute toxicity to Daphnia magna in a static 48-hour Immobilisation Test, Study No 127621220, March 2018 Sanofi internal report: Teicoplanin : Acute toxicity to Zebrafish (Danio rerio) Embryos in a 96-hour Static Test, Study No 127621238, March 2018 Sanofi internal report: Teicoplanin Sodium Salt: ready biodegradability in a manometric respirometry test, Study No 135541163, October 2018 Pubchem, Targocid, 61036-62-2, NCBI. Available: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=16131925, Accessed Feb 01, 2017 Vidal, 2013, Vidal Product monography – Targocid 100 mg lyoph sol DrugBank http://www.drugbank.ca/drugs/DB06149"
    },
    "skyddsinfo": {},
    "product_name": {
        "product_name": "Targocid®, Pulver till injektions-/infusionsvätska, lösning 200 mg"
    }
}